Scorpion venom components as potential candidates for drug development
暂无分享,去创建一个
Ernesto Ortiz | L. Possani | E. F. Schwartz | Lourival D Possani | G. Gurrola | E. Ortiz | Georgina B Gurrola | Elisabeth Ferroni Schwartz
[1] P. Perret,et al. Quantitative evaluation of the cell penetrating properties of an iodinated Tyr-L-maurocalcine analog. , 2014, Biochimica et biophysica acta.
[2] P. Harrison,et al. Antimicrobial peptides from scorpion venoms , 2014, Toxicon.
[3] Chunfu Wu,et al. Purification, characterization, and bioactivity of a new analgesic-antitumor peptide from Chinese scorpion Buthus martensii Karsch , 2014, Peptides.
[4] Qiang Zhang,et al. Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes. , 2014, Molecular pharmaceutics.
[5] C. Sorgi,et al. TLR2, TLR4 and CD14 Recognize Venom-Associated Molecular Patterns from Tityus serrulatus to Induce Macrophage-Derived Inflammatory Mediators , 2014, PloS one.
[6] A. Almaaytah,et al. Scorpion venom peptides with no disulfide bridges: A review , 2014, Peptides.
[7] M. Seno,et al. Chlorotoxin-Fc Fusion Inhibits Release of MMP-2 from Pancreatic Cancer Cells , 2014, BioMed research international.
[8] V. Quintero-Hernández,et al. Scorpion venom components that affect ion-channels function. , 2013, Toxicon : official journal of the International Society on Toxinology.
[9] M. Castanho,et al. From antimicrobial to anticancer peptides. A review , 2013, Front. Microbiol..
[10] Ran Wei,et al. Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities. , 2013, Biochimie.
[11] A. Gomes,et al. Bengalin initiates autophagic cell death through ERK-MAPK pathway following suppression of apoptosis in human leukemic U937 cells. , 2013, Life sciences.
[12] Lingli Zhou,et al. Three new antimicrobial peptides from the scorpion Pandinus imperator , 2013, Peptides.
[13] A. Díaz-García,et al. In vitro anticancer effect of venom from Cuban scorpion Rhopalurus junceus against a panel of human cancer cell lines , 2013, Journal of venom research.
[14] A. Rodríguez‐Romero,et al. Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin. , 2013, Biochimica et biophysica acta.
[15] L. Pereira de Almeida,et al. Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment , 2013, Molecular therapy. Nucleic acids.
[16] Nizar M. Mhaidat,et al. Mauriporin, a Novel Cationic α-Helical Peptide with Selective Cytotoxic Activity Against Prostate Cancer Cell Lines from the Venom of the Scorpion Androctonus mauritanicus , 2013, International Journal of Peptide Research and Therapeutics.
[17] M. Ronjat,et al. Cell Penetration Properties of a Highly Efficient Mini Maurocalcine Peptide , 2013, Pharmaceuticals.
[18] Yuejun Fu,et al. Adenovirus-mediated expression of BmK CT suppresses growth and invasion of rat C6 glioma cells , 2013, Biotechnology Letters.
[19] Yingliang Wu,et al. Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus , 2013, Biomaterials.
[20] I. Gould,et al. New antibiotic agents in the pipeline and how they can help overcome microbial resistance , 2013, Virulence.
[21] E. Villegas,et al. Antimicrobial peptides from arachnid venoms and their microbicidal activity in the presence of commercial antibiotics , 2012, The Journal of Antibiotics.
[22] Y. Rosenstein,et al. Vm24, a Natural Immunosuppressive Peptide, Potently and Selectively Blocks Kv1.3 Potassium Channels of Human T Cells , 2012, Molecular Pharmacology.
[23] Chao Dai,et al. Antibacterial Activity and Mechanism of a Scorpion Venom Peptide Derivative In Vitro and In Vivo , 2012, PloS one.
[24] J. Chippaux. Emerging options for the management of scorpion stings , 2012, Drug design, development and therapy.
[25] A. Almaaytah,et al. Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: Biochemical and functional characterization of natural peptides and a single site-substituted analog , 2012, Peptides.
[26] R. C. Rodríguez de la Vega,et al. Structure, function, and chemical synthesis of Vaejovis mexicanus peptide 24: a novel potent blocker of Kv1.3 potassium channels of human T lymphocytes. , 2012, Biochemistry.
[27] Yuejun Fu,et al. Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs , 2012, Journal of Neuro-Oncology.
[28] Fang Liu,et al. Anti-HIV-1 Activity of a New Scorpion Venom Peptide Derivative Kn2-7 , 2012, PloS one.
[29] V. Quintero-Hernández,et al. Gene cloning and functional characterization of four novel antimicrobial-like peptides from scorpions of the family Vaejovidae , 2012, Peptides.
[30] S. Serrano,et al. Bradykinin-potentiating peptides: beyond captopril. , 2012, Toxicon : official journal of the International Society on Toxinology.
[31] Nancy Fullman,et al. Global malaria mortality between 1980 and 2010: a systematic analysis , 2012, The Lancet.
[32] Lei Zhang,et al. Characterization of BmKbpp, a multifunctional peptide from the Chinese scorpion Mesobuthus martensii Karsch: Gaining insight into a new mechanism for the functional diversification of scorpion venom peptides , 2012, Peptides.
[33] M. Mrugala,et al. Outside the Box—Novel Therapeutic Strategies for Glioblastoma , 2012, Cancer journal.
[34] G. Schneider,et al. Designing antimicrobial peptides: form follows function , 2011, Nature Reviews Drug Discovery.
[35] V. Quintero-Hernández,et al. Scorpion and spider venom peptides: gene cloning and peptide expression. , 2011, Toxicon : official journal of the International Society on Toxinology.
[36] James M Olson,et al. In vivo bio-imaging using chlorotoxin-based conjugates. , 2011, Current pharmaceutical design.
[37] F. R. Nascimento,et al. Immune cells recruitment and activation by Tityus serrulatus scorpion venom. , 2011, Toxicon : official journal of the International Society on Toxinology.
[38] Shuang-quan Zhang,et al. Analgesic‐antitumor peptide inhibits proliferation and migration of SHG‐44 human malignant glioma cells , 2011, Journal of cellular biochemistry.
[39] Z. Cao,et al. Ctriporin, a New Anti-Methicillin-Resistant Staphylococcus aureus Peptide from the Venom of the Scorpion Chaerilus tricostatus , 2011, Antimicrobial Agents and Chemotherapy.
[40] Qiang Zhang,et al. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[41] C. Sorgi,et al. Tityus serrulatus venom and toxins Ts1, Ts2 and Ts6 induce macrophage activation and production of immune mediators. , 2011, Toxicon : official journal of the International Society on Toxinology.
[42] Z. Cao,et al. Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses , 2011, Peptides.
[43] Gergely Maróti,et al. Natural roles of antimicrobial peptides in microbes, plants and animals. , 2011, Research in microbiology.
[44] M. D. Waard,et al. Administration de molécules actives dans les cellules : Le potentiel des peptides de pénétration cellulaire , 2011 .
[45] T. E. Heinen,et al. Arthropod venoms and cancer. , 2011, Toxicon : official journal of the International Society on Toxinology.
[46] Angray S. Kang,et al. Development of Transgenic Fungi That Kill Human Malaria Parasites in Mosquitoes , 2011, Science.
[47] Z. Cao,et al. A new natural α-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV , 2011, Peptides.
[48] So Yeong Lee,et al. Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo. , 2011, European journal of pharmacology.
[49] R. C. Rodríguez de la Vega,et al. Mining on scorpion venom biodiversity. , 2010, Toxicon : official journal of the International Society on Toxinology.
[50] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[51] C. Sevcik,et al. Apoptogenic peptides from Tityus discrepans scorpion venom acting against the SKBR3 breast cancer cell line. , 2010, Toxicon : official journal of the International Society on Toxinology.
[52] G. Leung,et al. Invasion of human glioma cells is regulated by multiple chloride channels including ClC-3. , 2010, Anticancer research.
[53] D. Denning,et al. Candida tropicalis in human disease , 2010, Critical reviews in microbiology.
[54] Jinhua Zhao,et al. Preparation and in vitro evaluation of 131I-BmK CT as a glioma-targeted agent. , 2010, Cancer biotherapy & radiopharmaceuticals.
[55] Hui Liu,et al. BmKCT toxin inhibits glioma proliferation and tumor metastasis. , 2010, Cancer letters.
[56] Shunyi Zhu,et al. Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus. , 2010, Biochimie.
[57] V. Petricevich. Scorpion Venom and the Inflammatory Response , 2010, Mediators of inflammation.
[58] Yoshiaki Nakagawa,et al. A Novel Amphipathic Linear Peptide with Both Insect Toxicity and Antimicrobial Activity from the Venom of the Scorpion Isometrus maculatus , 2010, Bioscience, biotechnology, and biochemistry.
[59] Yibing Huang,et al. Alpha-helical cationic antimicrobial peptides: relationships of structure and function , 2010, Protein & Cell.
[60] J. Morschhäuser. Regulation of multidrug resistance in pathogenic fungi. , 2010, Fungal genetics and biology : FG & B.
[61] F. Verdonck,et al. Parabutoporin, a cationic amphipathic peptide from scorpion venom: much more than an antibiotic. , 2010, Toxicon : official journal of the International Society on Toxinology.
[62] A. Gomes,et al. A high molecular weight protein Bengalin from the Indian black scorpion (Heterometrus bengalensis C.L. Koch) venom having antiosteoporosis activity in female albino rats. , 2010, Toxicon : official journal of the International Society on Toxinology.
[63] A. Saha,et al. Apoptosis induction in human leukemic cells by a novel protein Bengalin, isolated from Indian black scorpion venom: through mitochondrial pathway and inhibition of heat shock proteins. , 2010, Chemico-biological interactions.
[64] M. Biancalana,et al. A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library , 2009, Proceedings of the National Academy of Sciences.
[65] Chao Dai,et al. Imcroporin, a New Cationic Antimicrobial Peptide from the Venom of the Scorpion Isometrus maculates , 2009, Antimicrobial Agents and Chemotherapy.
[66] M. Linton,et al. Quantum dot mediated imaging of atherosclerosis , 2009, Nanotechnology.
[67] Shunyi Zhu,et al. Structural and functional characterization of two genetically related meucin peptides highlights evolutionary divergence and convergence in antimicrobial peptides , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[68] M. Ronjat,et al. Maurocalcine as a Non Toxic Drug Carrier Overcomes Doxorubicin Resistance in the Cancer Cell Line MDA-MB 231 , 2009, Pharmaceutical Research.
[69] P. Vandenabeele,et al. Inhibition of spontaneous neutrophil apoptosis by parabutoporin acts independently of NADPH oxidase inhibition but by lipid raft‐dependent stimulation of Akt , 2009, Journal of leukocyte biology.
[70] Xia Li,et al. APD2: the updated antimicrobial peptide database and its application in peptide design , 2008, Nucleic Acids Res..
[71] Q. Wang,et al. Mucroporin, the First Cationic Host Defense Peptide from the Venom of Lychas mucronatus , 2008, Antimicrobial Agents and Chemotherapy.
[72] P. Gopalakrishnakone,et al. Isolation and characterization of a hyaluronidase from the venom of Chinese red scorpion Buthus martensi. , 2008, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.
[73] J. Chippaux,et al. Epidemiology of scorpionism: a global appraisal. , 2008, Acta tropica.
[74] Hui Liu,et al. Structural Basis of a Potent Peptide Inhibitor Designed for Kv1.3 Channel, a Therapeutic Target of Autoimmune Disease* , 2008, Journal of Biological Chemistry.
[75] T. Verano-Braga,et al. Tityus serrulatus Hypotensins: a new family of peptides from scorpion venom. , 2008, Biochemical and biophysical research communications.
[76] V. Petricevich,et al. Toxin gamma from Tityus serrulatus scorpion venom plays an essential role in immunomodulation of macrophages. , 2007, Toxicon : official journal of the International Society on Toxinology.
[77] J. Howl,et al. The many futures for cell-penetrating peptides: how soon is now? , 2007, Biochemical Society transactions.
[78] A. Saha,et al. Indian black scorpion (Heterometrus bengalensis Koch) venom induced antiproliferative and apoptogenic activity against human leukemic cell lines U937 and K562. , 2007, Leukemia research.
[79] Jinghai Zhang,et al. Analgesic Peptides in Buthus martensii Karsch: A Traditional Chinese Animal Medicine , 2007 .
[80] L. Bubendorf,et al. KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer , 2007, Oncogene.
[81] S. Levy,et al. Molecular Mechanisms of Antibacterial Multidrug Resistance , 2007, Cell.
[82] A. Mamelak,et al. Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601) , 2007, Expert opinion on drug delivery.
[83] R. Hancock,et al. Cationic host defence peptides: Innate immune regulatory peptides as a novel approach for treating infections , 2007, Cellular and Molecular Life Sciences.
[84] J. Tytgat,et al. Voltage-gated sodium channel modulation by scorpion alpha-toxins. , 2007, Toxicon : official journal of the International Society on Toxinology.
[85] B. Chai,et al. Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas , 2007, Neuroscience Letters.
[86] M. Pfaller,et al. Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.
[87] R. Hancock,et al. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.
[88] S. Griffey,et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases , 2006, Proceedings of the National Academy of Sciences.
[89] F. Verdonck,et al. The antimicrobial peptide parabutoporin competes with p47phox as a PKC‐substrate and inhibits NADPH oxidase in human neutrophils , 2006, FEBS letters.
[90] V. Petricevich. Balance Between Pro- and Anti-Inflammatory Cytokines in Mice Treated With Centruroides noxius Scorpion Venom , 2006, Mediators of inflammation.
[91] M. Gonda,et al. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[92] R. C. Rodríguez de la Vega,et al. K+ channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression. , 2006, Current pharmaceutical design.
[93] R. C. Rodríguez de la Vega,et al. Overview of scorpion toxins specific for Na+ channels and related peptides: biodiversity, structure-function relationships and evolution. , 2005, Toxicon : official journal of the International Society on Toxinology.
[94] Daniela Trinca Bertazzi,et al. Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom. , 2005, International immunopharmacology.
[95] A. Mamelak,et al. Imaging glioma extent with 131I-TM-601. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[96] G. Corzo,et al. Scorpion Venom Peptides without Disulfide Bridges , 2005, IUBMB life.
[97] Graeme Morgan,et al. The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).
[98] H. Sontheimer,et al. Role for calcium‐activated potassium channels (BK) in growth control of human malignant glioma cells , 2004, Journal of neuroscience research.
[99] Michael Pennington,et al. K+ channels as targets for specific immunomodulation. , 2004, Trends in pharmacological sciences.
[100] Shun Zhu,et al. Identification and functional characterization of novel scorpion venom peptides with no disulfide bridge from Buthus martensii Karsch , 2004, Peptides.
[101] T. Kawai,et al. Selective Blockade of Voltage‐Gated Potassium Channels Reduces Inflammatory Bone Resorption in Experimental Periodontal Disease , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[102] L. Kuhn-Nentwig. Antimicrobial and cytolytic peptides of venomous arthropods , 2003, Cellular and Molecular Life Sciences CMLS.
[103] F. Verdonck,et al. Antimicrobial peptides from scorpion venom induce Ca(2+) signaling in HL-60 cells. , 2003, Biochemical and biophysical research communications.
[104] Harald Sontheimer,et al. Chlorotoxin Inhibits Glioma Cell Invasion via Matrix Metalloproteinase-2* , 2003, The Journal of Biological Chemistry.
[105] Chun-Fu Wu,et al. Expression of an antitumor-analgesic peptide from the venom of Chinese scorpion Buthus martensii karsch in Escherichia coli. , 2003, Protein expression and purification.
[106] Xian-Chun Zeng,et al. Identification of BmKAPi, a novel type of scorpion venom peptide with peculiar disulfide bridge pattern from Buthus martensii Karsch. , 2002, Toxicon : official journal of the International Society on Toxinology.
[107] F. Verdonck,et al. Cationic peptides from scorpion venom can stimulate and inhibit polymorphonuclear granulocytes. , 2002, Toxicon : official journal of the International Society on Toxinology.
[108] F. Verdonck,et al. Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa. , 2002, European journal of biochemistry.
[109] Jan Tytgat,et al. An overview of toxins and genes from the venom of the Asian scorpion Buthus martensi Karsch. , 2002, Toxicon : official journal of the International Society on Toxinology.
[110] H. Sontheimer,et al. Chlorotoxin, a scorpion‐derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin , 2002, Glia.
[111] R. Kraft,et al. BK channel blockers inhibit potassium-induced proliferation of human astrocytoma cells , 2002, Neuroreport.
[112] K. Chandy,et al. Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[113] R. Norton,et al. Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator. , 2001, The Biochemical journal.
[114] H. Naoki,et al. IsCT, a novel cytotoxic linear peptide from scorpion Opisthacanthus madagascariensis. , 2001, Biochemical and biophysical research communications.
[115] P. Giraud,et al. Selective Blocking of Voltage-Gated K+ Channels Improves Experimental Autoimmune Encephalomyelitis and Inhibits T Cell Activation1 , 2001, The Journal of Immunology.
[116] A. Torres-Larios,et al. Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus. , 2000, European journal of biochemistry.
[117] D. Jiang,et al. Cloning and characterization of the cDNA sequences of two venom peptides from Chinese scorpion Buthus martensii Karsch (BmK). , 2000, Toxicon : official journal of the International Society on Toxinology.
[118] J. J. Wu,et al. The gene cloning and sequencing of Bm-12, a chlorotoxin-like peptide from the scorpion Buthus martensi Karsch. , 2000, Toxicon : official journal of the International Society on Toxinology.
[119] L. Possani,et al. Scorpine, an anti‐malaria and anti‐bacterial agent purified from scorpion venom , 2000, FEBS letters.
[120] M. Aparecida,et al. Scorpion venom‐induced neutrophilia is inhibited by a PAF receptor antagonist in the rat , 2000, Journal of leukocyte biology.
[121] P. Allen,et al. Chemical synthesis and characterization of maurocalcine, a scorpion toxin that activates Ca2+ release channel/ryanodine receptors , 2000, FEBS letters.
[122] K. Kavanagh,et al. Emergence of Saccharomyces cerevisiae as a human pathogen: Implications for biotechnology , 1999 .
[123] A. Schwab,et al. K+ Channel-Dependent Migration of Fibroblasts and Human Melanoma Cells , 1999, Cellular Physiology and Biochemistry.
[124] R. Gazzinelli,et al. Serum levels of cytokines in patients envenomed by Tityus serrulatus scorpion sting. , 1999, Toxicon : official journal of the International Society on Toxinology.
[125] A. Bordey,et al. Expression of voltage-activated chloride currents in acute slices of human gliomas , 1998, Neuroscience.
[126] N. Sigal,et al. Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. , 1997, Journal of immunology.
[127] H. Sontheimer,et al. Biophysical and pharmacological characterization of chloride currents in human astrocytoma cells. , 1996, The American journal of physiology.
[128] H. Rochat,et al. A bradykinin-potentiating peptide (peptide K12) isolated from the venom of Egyptian scorpion Buthus occitanus , 1995, Peptides.
[129] H. Sontheimer,et al. Human astrocytoma cells express a unique chloride current. , 1995, Neuroreport.
[130] H. Sontheimer,et al. Human astrocytoma cells express a unique chloride current , 1995, Neuroreport.
[131] S. Wodak,et al. NMR sequential assignments and solution structure of chlorotoxin, a small scorpion toxin that blocks chloride channels. , 1995, Biochemistry.
[132] S. Sternberg. The emerging fungal threat. , 1994, Science.
[133] M. Garcia-Calvo,et al. Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels. , 1993, The Journal of biological chemistry.
[134] E. W. Alves,et al. Peptide T, a novel bradykinin potentiator isolated from Tityus serrulatus scorpion venom. , 1993, Toxicon : official journal of the International Society on Toxinology.
[135] G. Strichartz,et al. Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion. , 1993, The American journal of physiology.
[136] W. Lederer,et al. Scorpion toxins targeted against the sarcoplasmic reticulum Ca(2+)-release channel of skeletal and cardiac muscle. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[137] G. Giménez-Gallego,et al. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. , 1990, The Journal of biological chemistry.
[138] G. Polis,et al. The Biology of Scorpions , 1990 .
[139] M. Lazdunski,et al. Charybdotoxin is a new member of the K+ channel toxin family that includes dendrotoxin I and mast cell degranulating peptide. , 1989, Biochemistry.
[140] M. Navia,et al. Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[141] K. Chandy,et al. Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? , 1984, Nature.
[142] M. Rimsza,et al. Scorpion envenomation. , 1980, Pediatrics.
[143] P. Aronowitz,et al. Invasive Aspergillosis , 2013, Journal of General Internal Medicine.
[144] C. Mathers,et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .
[145] Jie Yu,et al. Anti-HIV-1 Activity of a New Scorpion Venom Peptide Derivative Kn 2-7 , 2012 .
[146] A. Rodríguez‐Romero,et al. Vejovine, a new antibiotic from the scorpion venom of Vaejovis mexicanus. , 2011, Toxicon : official journal of the International Society on Toxinology.
[147] M. De Waard,et al. [Potential of cell penetrating peptides for cell drug delivery]. , 2011, Medecine sciences : M/S.
[148] S. Mousa,et al. Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide. , 2010, Anticancer research.
[149] E. Ythier,et al. Scorpions of the world , 2010 .
[150] J. D. Burke,et al. Antiviral strategies: the present and beyond. , 2009, Current molecular pharmacology.
[151] Burke Jd,et al. Antiviral strategies: the present and beyond. , 2009 .
[152] J. Tytgat,et al. Voltage-gated sodium channel modulation by scorpion alpha-toxins. , 2007, Toxicon : official journal of the International Society on Toxinology.
[153] F. Tomita,et al. ISOLATION AND CHARACTERIZATION OF FLAVONOID COMPOUND FROM FERONIA LIMONIA , 2015 .
[154] S. Grissmer,et al. K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom. , 2005, The Biochemical journal.
[155] Cao Zhi. Functional Analysis of a Gene Encoding a Chlorotoxin-like Peptide Derived from Scorpion Toxin , 2005 .
[156] E Blanc,et al. Solution structure of BmKTX, a K+ blocker toxin from the Chinese scorpion Buthus Martensi , 2000, Proteins.
[157] V. Kosma,et al. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. , 2000, Cancer research.
[158] K. Ádám,et al. Scorpion venom. , 1959, Zeitschrift fur Tropenmedizin und Parasitologie.